Articles by Randall C Willis

Cancer heterogeneity can make therapy feel like whack-a-mole

When it comes to anecdotes vs. evidence, people often latch on to highly touted 'remedies' in the news and social media feeds that are often more rumor or hype than actual promise. However, even in the anecdotes, we sometimes find the beginning of wisdom that leads to development and clinical testing of potential therapeutics.

Analgesia remains a chronic challenge

Medical journals aren't featuring as many basic science articles as they once did, and we should all be worried about that and what it bodes for precision medicine efforts and perhaps drug discovery and development more generally, too.

We must strive to avoid getting swept up in hype and then forget or minimize existing limitations and challenges as we try to turn exciting discoveries into life-altering products and services

Regenerative medicine turns its focus on the eye

Despite so many achievements in pharma and biotech, the developing world continues to be ravaged by microbial infection, and that's something we ought to pay more attention to

Researchers follow epigenetic fingerprints to understand (and perhaps treat) autoimmune disease.

To avoid tissue biopsy, researchers are turning to diagnostic biofluids

In our zeal to standardize healthcare and make medicine more scientific, we have to be careful not to ignore the natural variabilities of individuals within those populations

After engineering SuperRat, is Superman far behind?

Pharmas and biotechs of all sizes would benefit greatly by a small investment of time and money into cameras and making photos of their executives and operations easily accessible